Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
出版年份 2021 全文链接
标题
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
作者
关键词
-
出版物
mBio
Volume 12, Issue 2, Pages -
出版商
American Society for Microbiology
发表日期
2021-04-05
DOI
10.1128/mbio.03681-20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Repurposed Drugs That Block the Gonococcus-Complement Receptor 3 Interaction Can Prevent and Cure Gonococcal Infection of Primary Human Cervical Epithelial Cells
- (2020) Jessica Poole et al. mBio
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate
- (2020) Ji Youn Lee et al. NUCLEAR MEDICINE AND BIOLOGY
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
- (2020) José Antonio Encinar et al. Viruses-Basel
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
- (2020) Clarisse Salgado-Benvindo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
- (2020) Marta Menegazzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In silico Drug Repurposing for COVID‐19: Targeting SARS‐CoV‐2 Proteins through Docking and Consensus Ranking
- (2020) Claudio Cavasotto et al. Molecular Informatics
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy
- (2020) Shimaa A. Ahmed et al. STRUCTURAL CHEMISTRY
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- (2020) Franck Touret et al. Scientific Reports
- Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
- (2020) Shweta Choudhary et al. Frontiers in Immunology
- Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
- (2020) Pritam Kumar Panda et al. Science Advances
- Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
- (2020) Mark Roschewski et al. Science Immunology
- Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
- (2020) Deep Bhowmik et al. INFECTION GENETICS AND EVOLUTION
- Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase
- (2020) Mark Andrew White et al. Journal of Physical Chemistry Letters
- Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
- (2020) Claudia Guadalupe Benítez-Cardoza et al. LIFE SCIENCES
- Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study
- (2020) Faezeh Sadat Hosseini et al. LIFE SCIENCES
- De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
- (2020) Longxing Cao et al. SCIENCE
- An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
- (2020) Alfonso Trezza et al. Scientific Reports
- SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
- (2020) Ali A. Rabaan et al. Annals of Clinical Microbiology and Antimicrobials
- Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro
- (2020) Melle Holwerda et al. Microorganisms
- Discovery of the Pan-genotypic Hepatitis C Virus NS3/4A Protease Inhibitor Voxilaprevir (GS-9857): A Component of Vosevi ®
- (2019) James G. Taylor et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors
- (2019) Daniel F. Earley et al. ACS Infectious Diseases
- Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models
- (2019) Simon P. Langdon et al. Scientific Reports
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
- (2018) Femke M. de Man et al. CLINICAL PHARMACOKINETICS
- Evans Blue Dye: A Revisit of Its Applications in Biomedicine
- (2018) Linpeng Yao et al. Contrast Media & Molecular Imaging
- “Albumin Hitchhiking” with an Evans Blue Analog for Cancer Theranostics
- (2018) Emily B. Ehlerding et al. Theranostics
- Clinical Use of Digitalis: A State of the Art Review
- (2018) Thomas F. Whayne American Journal of Cardiovascular Drugs
- Interferon epsilon promotes HIV restriction at multiple steps of viral replication
- (2017) Albert Garcia-Minambres et al. IMMUNOLOGY AND CELL BIOLOGY
- Levodopa in Parkinson’s Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis
- (2017) Amélie Marsot et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy
- (2017) V K Patel et al. LEUKEMIA
- Coronary stents: historical development, current status and future directions
- (2013) J. Iqbal et al. BRITISH MEDICAL BULLETIN
- Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2013) John O. Link et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study
- (2013) James M. Balkovec et al. NATURAL PRODUCT REPORTS
- X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
- (2010) Kate L. Jones et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started